Literature DB >> 11877402

Cytotoxic necrotizing factor-1 contributes to Escherichia coli K1 invasion of the central nervous system.

Naveed Ahmed Khan1, Ying Wang, Kee Jun Kim, Jin Woong Chung, Carol Ann Wass, Kwang Sik Kim.   

Abstract

Escherichia coli K1 invasion of brain microvascular endothelial cells (BMECs) is a prerequisite for penetration into the central nervous system and requires actin cytoskeletal rearrangements. Here, we demonstrate that E. coli K1 invasion of BMECs requires RhoA activation. In addition, we show that cytotoxic necrotizing factor-1 (CNF1) contributes to E. coli K1 invasion of brain endothelial cells in vitro and traversal of the blood-brain barrier in the experimental hematogenous meningitis animal model. These in vitro and in vivo effects of CNF1 were dependent upon RhoA activation as shown by (a) decreased invasion and RhoA activation with the Delta cnf1 mutant of E. coli K1 and (b) restoration of invasion frequency of the Delta cnf1 mutant to the level of the parent E. coli K1 strain in BMECs with constitutively active RhoA. In addition, CNF1-enhanced E. coli invasion of brain endothelial cells and stress fiber formation were independent of focal adhesion kinase and phosphatidylinositol 3-kinase activation. This is the first demonstration that CNF1 contributes to E. coli K1 invasion of BMECs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11877402     DOI: 10.1074/jbc.M112224200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Prevention of Escherichia coli K1 penetration of the blood-brain barrier by counteracting the host cell receptor and signaling molecule involved in E. coli invasion of human brain microvascular endothelial cells.

Authors:  Longkun Zhu; Donna Pearce; Kwang Sik Kim
Journal:  Infect Immun       Date:  2010-06-01       Impact factor: 3.441

2.  Extracellular loops of the Eschericia coli outer membrane protein A contribute to the pathogenesis of meningitis.

Authors:  Ravi Maruvada; Kwang Sik Kim
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

Review 3.  Covert operations of uropathogenic Escherichia coli within the urinary tract.

Authors:  Jean M Bower; Danelle S Eto; Matthew A Mulvey
Journal:  Traffic       Date:  2005-01       Impact factor: 6.215

4.  Effects of ompA deletion on expression of type 1 fimbriae in Escherichia coli K1 strain RS218 and on the association of E. coli with human brain microvascular endothelial cells.

Authors:  Ching-Hao Teng; Yi Xie; Sooan Shin; Francescopaolo Di Cello; Maneesh Paul-Satyaseela; Mian Cai; Kwang Sik Kim
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

5.  Novel model to study virulence determinants of Escherichia coli K1.

Authors:  Naveed Ahmed Khan; Graham John Goldsworthy
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

6.  Cleavage of Escherichia coli cytotoxic necrotizing factor 1 is required for full biologic activity.

Authors:  Zeynep Knust; Britta Blumenthal; Klaus Aktories; Gudula Schmidt
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

Review 7.  Concepts and mechanisms: crossing host barriers.

Authors:  Kelly S Doran; Anirban Banerjee; Olivier Disson; Marc Lecuit
Journal:  Cold Spring Harb Perspect Med       Date:  2013-07-01       Impact factor: 6.915

8.  Ferredoxin is involved in secretion of cytotoxic necrotizing factor 1 across the cytoplasmic membrane in Escherichia coli K1.

Authors:  Hao Yu; Kwang Sik Kim
Journal:  Infect Immun       Date:  2009-11-16       Impact factor: 3.441

9.  Use of diagnostic microarrays for determination of virulence gene patterns of Escherichia coli K1, a major cause of neonatal meningitis.

Authors:  Bozena Korczak; Joachim Frey; Jacques Schrenzel; Gerd Pluschke; Riccardo Pfister; Ralf Ehricht; Peter Kuhnert
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

Review 10.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.